19 Results for "

Abemaciclib

" in MedChemExpress (MCE) Product Catalog:
Products (19)

19 Results for "Abemaciclib" in MCE Product Catalog:

125
125 Publications Verification
Cat. No.: HY-16297A
CAS No.: 1231929-97-7
Synonyms: LY2835219
Target:  

CDK

Research Areas:  

Neurological Disease Cancer

Abemaciclib (LY2835219) is a selective and BBB-permeable CDK4/6 inhibitor with IC50 values of 2 nM and 10 nM for CDK4 and CDK6, respectively.
loading...
    loading...
125
125 Publications Verification
Cat. No.: HY-16297
CAS No.: 1231930-82-7
Synonyms: LY2835219 methanesulfonate
Target:  

CDK

Research Areas:  

Cancer

Abemaciclib methanesulfonate (LY2835219 methanesulfonate) is a selective and BBB-permeable CDK4/6 inhibitor with IC50s of 2 nM and 10 nM for CDK4 and CDK6, respectively .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-129336
CAS No.: 2138499-06-4
Purity:  96.02%
Synonyms: LSN3106726
Target:  

CDK

Research Areas:  

Cancer

Abemaciclib metabolite M20 (LSN3106726), the active metabolite of Abemaciclib, is a selective CDK4/6 inhibitor for the treatment of cancer .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-126534A
CAS No.: 2704316-82-3
Purity:  98.18%
Synonyms: LSN3106729 hydrochloride
Research Areas:  

Cancer

Abemaciclib metabolite M18 (LSN3106729) hydrochloride, the metabolite of Abemaciclib (HY-16297A), is a CDK inhibitor with antitumor activity. Abemaciclib metabolite M18 hydrochloride and a CRBN ligand have been used to design PROTAC CDK4/6 degrader .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-128669
CAS No.: 1231930-57-6
Purity:  99.75%
Synonyms: LSN2839567
Target:  

CDK Drug Metabolite

Research Areas:  

Cancer

Abemaciclib metabolite M2 (LSN2839567) is a metabolite of Abemaciclib, acts as a potent CDK4 and CDK6 inhibitor, with IC50s of 1.2 and 1.3 nM, respectively. Anti-cancer activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-126534
CAS No.: 2704316-81-2
Purity:  98.01%
Synonyms: LSN3106729
Research Areas:  

Cancer

Abemaciclib metabolite M18 (LSN3106729), the metabolite of Abemaciclib (HY-16297A), is a CDK inhibitor with antitumor activity. Abemaciclib metabolite M18 and a CRBN ligand have been used to design PROTAC CDK4/6 degrader .
loading...
    loading...
Cat. No.: HY-16297AR
CAS No.: 1231929-97-7
Synonyms: LY2835219 (Standard)
Target:  

Reference Standards CDK

Research Areas:  

Cancer

Abemaciclib (Standard) is the analytical standard of Abemaciclib. This product is intended for research and analytical applications. Abemaciclib (LY2835219) is a selective and BBB-permeable CDK4/6 inhibitor with IC50 values of 2 nM and 10 nM for CDK4 and CDK6, respectively.
loading...
    loading...
Cat. No.: HY-16297AS
CAS No.: 2088650-53-5
Synonyms: LY2835219-d8
Abemaciclib-d8 is the deuterium labeled Abemaciclib. Abemaciclib (LY2835219) is a selective CDK4/6 inhibitor with IC50 values of 2 nM and 10 nM for CDK4 and CDK6, respectively.
loading...
    loading...
Cat. No.: HY-129336S
Purity:  97.01%
Synonyms: LSN3106726-d8
Abemaciclib metabolite M20-d8 is the deuterium labeled Abemaciclib metabolite M20. Abemaciclib metabolite M20 (LSN3106726), the active metabolite of Abemaciclib, is a selective CDK4/6 inhibitor .
loading...
    loading...
Cat. No.: HY-128669S
Purity:  99.25%
Synonyms: LSN2839567-d6
Abemaciclib metabolite M2-d6 is the deuterium labeled Abemaciclib metabolite M2. Abemaciclib metabolite M2 (LSN2839567) is a metabolite of Abemaciclib, acts as a potent CDK4 and CDK6 inhibitor, with IC50s in the range of 1-3 nM. Anti-cancer activity .
loading...
    loading...
Cat. No.: HY-78066
CAS No.: 1231930-33-8
Synonyms: 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
Target:  

Drug Intermediate

Research Areas:  

Others

Abemaciclib Impurity 1 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole) is a drug intermediate for synthesis of various active compounds.
loading...
    loading...
Cat. No.: HY-168996
CAS No.: 3032908-44-1
Target:  

CDK Apoptosis

Research Areas:  

Cancer

LA-CB1 is an Abemaciclib (HY-16297A) derivative that targets CDK4/6 and promotes its degradation via the ubiquitin-proteasome pathway, thereby disrupting the CDK4/6-Cyclin D1-Rb-E2F axis and inducing G0/G1 cell cycle arrest and apoptosis. LA-CB1 exhibits antiproliferative activity against MDA-MB-231 cells, with an IC50 of 0.27 µM, and effectively inhibits epithelial-mesenchymal transition (EMT), cell migration, invasion, and angiogenesis. In highly aggressive models such as triple-negative breast cancer (TNBC), LA-CB1 significantly suppresses tumor growth in a dose-dependent manner. LA-CB1 holds potential for research in the field of breast cancer .
loading...
    loading...
Cat. No.: HY-16297R
CAS No.: 1231930-82-7
Synonyms: LY2835219 methanesulfonate (Standard)
Target:  

Reference Standards CDK

Research Areas:  

Cancer

Abemaciclib (methanesulfonate) (Standard) is the analytical standard of Abemaciclib (methanesulfonate). This product is intended for research and analytical applications. Abemaciclib methanesulfonate (LY2835219 methanesulfonate) is a selective CDK4/6 inhibitor with IC50s of 2 nM and 10 nM for CDK4 and CDK6, respectively .
loading...
    loading...
Cat. No.: HY-126534S
Purity:  98.47%
Synonyms: LSN3106729-d8
Abemaciclib metabolite M18-d8 is the deuterium labeled Abemaciclib metabolite M18. Abemaciclib metabolite M18 (LSN3106729), the metabolite of Abemaciclib (HY-16297A), is a CDK inhibitor with antitumor activity. Abemaciclib metabolite M18 and a CRBN ligand have been used to design PROTAC CDK4/6 degrader .
loading...
    loading...
Cat. No.: HY-W728130
CAS No.: 1809251-51-1
Synonyms: LY2835219-d5
Abemaciclib-d5 (LY2835219-d5) is a deuterium labeled Abemaciclib (HY-16297A) .
loading...
    loading...
Cat. No.: HY-128669R
CAS No.: 1231930-57-6
Synonyms: LSN2839567 (Standard)
Research Areas:  

Cancer

Abemaciclib metabolite M2 (Standard) is the analytical standard of Abemaciclib metabolite M2. This product is intended for research and analytical applications. Abemaciclib metabolite M2 (LSN2839567) is a metabolite of Abemaciclib, acts as a potent CDK4 and CDK6 inhibitor, with IC50s of 1.2 and 1.3 nM, respectively. Anti-cancer activity[1][2].
loading...
    loading...
Cat. No.: HY-162985
Target:  

CDK

Research Areas:  

Cancer

JHD205 is a CDK4/6 inhibitor that induces apoptosis and DNA damage. JHD205 inhibits DNA repair by upregulating Caspase3 and p-H2AX. JHD205 has superior potency to Abemaciclib (HY-16297A) in a xenograft chick embryo breast cancer model. .
loading...
    loading...
Cat. No.: HY-78066S
Synonyms: 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-d12
Abemaciclib impurity 1-d12 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-d12) is the deuterium labeled Abemaciclib impurity 1. Abemaciclib Impurity 1 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole) is a drug intermediate for synthesis of various active compounds.
loading...
    loading...
Cat. No.: HY-78066S1
CAS No.: 2088650-87-5
Synonyms: 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-d5
Abemaciclib impurity 1-d5 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-d5) is the deuterium labeled Abemaciclib impurity 1. Abemaciclib Impurity 1 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole) is a drug intermediate for synthesis of various active compounds.
loading...
    loading...
  • 1